Reuters logo
BRIEF-U.S. FDA accepts regulatory submission and grants priority review for US Worldmeds' Lofexidine
November 21, 2017 / 1:14 PM / 21 days ago

BRIEF-U.S. FDA accepts regulatory submission and grants priority review for US Worldmeds' Lofexidine

Nov 21 (Reuters) -

* U.S. FDA accepts regulatory submission and grants priority review for US Worldmeds’ Lofexidine

* ‍US Worldmeds - U.S. FDA has accepted and granted priority review of New Drug Application for Lofexidine​ Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below